Direct comparison of enoxaparin and nadroparin in a rabbit model of arterial thrombosis prevention
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu srovnávací studie, časopisecké články
PubMed
20382412
DOI
10.1016/j.thromres.2010.03.001
PII: S0049-3848(10)00173-8
Knihovny.cz E-zdroje
- MeSH
- arterie MeSH
- enoxaparin terapeutické užití MeSH
- heparin nízkomolekulární terapeutické užití MeSH
- heparin terapeutické užití MeSH
- klinické zkoušky jako téma MeSH
- králíci MeSH
- nadroparin terapeutické užití MeSH
- trombóza farmakoterapie prevence a kontrola MeSH
- zvířata MeSH
- Check Tag
- králíci MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
- Názvy látek
- enoxaparin MeSH
- heparin nízkomolekulární MeSH
- heparin MeSH
- nadroparin MeSH
INTRODUCTION: The aim of the study was to evaluate and compare the efficacy of standard unfractionated heparin (UFH) and low-molecular weight heparins (LMWH's). MATERIALS AND METHODS: We modified a previously published rabbit model of arterial thrombosis prevention [1,2] to compare unfractionated heparin and two different doses of two low-molecular weight heparin fragments--nadroparin and enoxaparin. Thrombosis in the distal aorta was triggered by vessel wall injury and critical stenosis. Blood flow in the damaged arterial segment was monitored by a flow probe placed distal to the constrictor. The primary endpoints of the study were: (1) cumulative flow, (2) time to occlusion and (3) residual clot weight. Thirty six animals were split into 6 groups with six animals in each group. Control groups were given saline or heparin and four more groups were used to compare LMWH's at 2 different doses. RESULTS: In our study, all treatments were superior to the saline control group (alpha
Citace poskytuje Crossref.org